Literature DB >> 12083784

Secretory production of recombinant human C-reactive protein in Escherichia coli, capable of binding with phosphorylcholine, and its characterization.

Toshio Tanaka1, Takekazu Horio, Yuhsi Matuo.   

Abstract

Recombinant human CRP (rhCRP) was secreted into culture supernatant of Escherichia coli by co-expressing kil gene that has a function to secrete colicin E1 outside the cell. Highly purified 5 g rhCRP was produced from 180 L culture supernatant by affinity chromatography. The purified rhCRP was indistinguishable from the native one with respect to Ca(2+)-dependent binding ability to phosphorylcholine, electrophoretic behavior, N-terminal amino acid analysis, and immunochemical properties. The molecular weight of rhCRP monomer was determined to be 23059.7 Da by TOF/MS analysis. These results indicate that rhCRP has the same protein structure as native one and that rhCRP has the potential as a reference material and/or calibrator of high-sensitivity CRP assay to predict the risk of cardiovascular disease. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083784     DOI: 10.1016/s0006-291x(02)00622-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Neutrophil responses to CRP are not dependent on polymorphism of human FcgammaRIIA (R131H).

Authors:  J A Rodríguez; K B Bodman-Smith; J G Raynes
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

2.  Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.

Authors: 
Journal:  Clin Biochem Rev       Date:  2004

3.  Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Authors:  Mark B Pepys; Philip N Hawkins; Melvyn C Kahan; Glenys A Tennent; J Ruth Gallimore; David Graham; Caroline A Sabin; Arturo Zychlinsky; Juana de Diego
Journal:  Circ Res       Date:  2005-10-27       Impact factor: 17.367

4.  Optimization of the secretory expression of recombinant human C-reactive protein in Pichia pastoris.

Authors:  Junming Li; Chengming Sun; Lei Chen; Lihui Sun; Lijun Duan; Qing Zheng; Xuejun Hu
Journal:  3 Biotech       Date:  2017-08-29       Impact factor: 2.406

5.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

6.  Conformational folding and disulfide bonding drive distinct stages of protein structure formation.

Authors:  Jian-Min Lv; Shou-Qin Lü; Zu-Pei Liu; Juan Zhang; Bo-Xuan Gao; Zhen-Yu Yao; Yue-Xin Wu; Lawrence A Potempa; Shang-Rong Ji; Mian Long; Yi Wu
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

7.  Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.

Authors:  Mark B Pepys; J Ruth Gallimore; Joanne Lloyd; Zhanhong Li; David Graham; Graham W Taylor; Stephan Ellmerich; Palma P Mangione; Glenys A Tennent; Winston L Hutchinson; David J Millar; Gary Bennett; John More; David Evans; Yogesh Mistry; Stephen Poole; Philip N Hawkins
Journal:  J Immunol Methods       Date:  2012-07-31       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.